VRDN
Viridian Therapeutics, Inc. Common Stock
$33.12
2.33%
+0.75
Notify me if price changes either direction
Buy VRDN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.1B
Enterprise value
2.9B
Trailing PE
-10.726384464227
Forward PE
-9.313916
PEG Ratio
0.15228817449211
Enterprise to EBITDA
-8.839
Enterprise to revenue
40.474
Price to book MRQ
8.6204195
Price to sales TTM
44.398216
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
70.8M
EBITDA
-324155008
Diluted EPS TTM
-3.03
Total Cash (MRQ)
490.9M
Current ratio (MRQ)
11.281
Operating Cash Flow (TTM)
-325968992
VRDN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
